What did @stevengrgas0 actually say?
The creator walked through what they called "everything you gotta know" before starting CJC-1295 with ipamorelin, describing it as a growth hormone secretagogue that tells "your brain to make more growth hormone at night." They said you pin five times a week before bed, which spikes growth hormone and, in turn, spikes insulin resistance. The takeaway was a two-hour pre-bed eating window to avoid carb or sugar-dense foods. They closed by calling the combination "a building and cutting peptide on one."
A few things to unpack here. Some of it is directionally correct. Some of it is oversimplified in ways that could cause problems for people taking this seriously.
Does the science back this up?
Partially. The core mechanism is real, but the framing of insulin resistance as a predictable nightly spike is where the creator overstates certainty.
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH). Ipamorelin is a ghrelin mimetic and growth hormone secretagogue receptor agonist. Used together, they work on two separate pathways to amplify pulsatile GH release. Teichman et al. (2006, Journal of Clinical Endocrinology and Metabolism) confirmed that CJC-1295 produced sustained increases in GH and IGF-1 in healthy adults. That part checks out.
The insulin resistance connection is real but nuanced. Growth hormone is a counter-regulatory hormone that suppresses insulin signaling, particularly in skeletal muscle. Moller and Jorgensen (2009, Endocrine Reviews) documented that acute GH elevation raises free fatty acids and blunts glucose uptake. The creator's advice to avoid carb-heavy meals near injection time has a legitimate physiological basis. But framing it as a guaranteed "spike" every single night is an oversimplification. GH secretion is pulsatile and variable, and the degree of insulin antagonism depends on baseline metabolic health, dose, and timing.
What did they get wrong (or right)?
They got the directional logic right on the eating window, but got sloppy on the mechanism and made an unsupported body recomposition claim.
Right: Avoiding dense carbohydrate loads close to injection is a reasonable precaution. GH and insulin genuinely compete, and eating high-glycemic foods around a GH pulse can blunt the secretagogue effect. This is consistent with basic endocrinology.
Wrong: Calling this a guaranteed insulin resistance "spike" every night is imprecise. Chronic, supraphysiologic GH elevation does impair insulin sensitivity over time, but a single pulsatile release is not the same as insulin resistance in the clinical sense. Saying it casually conflates a transient physiological response with a metabolic condition.
Also wrong: The "building and cutting peptide on one" claim is not supported by controlled human evidence. Studies like Walker et al. (2019, Frontiers in Endocrinology) note that GH secretagogues may improve body composition in GH-deficient populations, but extrapolating that to healthy adults doing simultaneous muscle gain and fat loss is a stretch the data does not support. The creator presents this as settled fact. It is not.
What should you actually know?
CJC-1295 with ipamorelin is not a casual supplement stack. These are injectable peptides with meaningful hormonal effects, and the regulatory environment around them is shifting fast.
The FDA placed CJC-1295 on its list of peptides withdrawn from compounding eligibility in 2024, citing lack of clinical evidence of safety and effectiveness at compounded doses. That matters. If you are sourcing this from a telehealth platform or compounding pharmacy, the legal and safety landscape has changed significantly.
Beyond the regulatory piece, users should know that long-term GH axis stimulation carries real monitoring considerations. IGF-1 levels, fasting glucose, and HbA1c are worth tracking. Insulin sensitivity changes are not always symptomatic in the short term. Anyone using these compounds should be doing so under medical supervision with bloodwork, not based on a TikTok video, regardless of how confident the creator sounds.
The five-days-per-week pinning frequency mentioned in the video is also presented without clinical context. Dosing schedules in the existing literature vary substantially, and there is no universal protocol that applies to every person's baseline GH output, age, or goals.